303 related articles for article (PubMed ID: 8423042)
41. Renal functional reserve and nitric oxide in patients with compensated liver cirrhosis.
Woitas RP; Heller J; Stoffel-Wagner B; Spengler U; Sauerbruch T
Hepatology; 1997 Oct; 26(4):858-64. PubMed ID: 9328305
[TBL] [Abstract][Full Text] [Related]
42. Arachidonic acid derivatives and renal function in liver cirrhosis.
Laffi G; La Villa G; Pinzani M; Marra F; Gentilini P
Semin Nephrol; 1997 Nov; 17(6):530-48. PubMed ID: 9353864
[TBL] [Abstract][Full Text] [Related]
43. Interrelationships between systemic hemodynamics, urinary sodium excretion, and renin-angiotensin system in cirrhosis.
Aliaga L; Zozoya JM; Omar M; Mediavilla JD; Prieto J
Acta Gastroenterol Belg; 1995; 58(2):213-21. PubMed ID: 7571982
[TBL] [Abstract][Full Text] [Related]
44. Renal effects of acute isosorbide-5-mononitrate administration in cirrhosis.
Salmerón JM; Ruiz del Arbol L; Ginès A; García-Pagán JC; Ginès P; Feu F; Claria J; Rivera F; Bosch J; Arroyo V
Hepatology; 1993 May; 17(5):800-6. PubMed ID: 8491447
[TBL] [Abstract][Full Text] [Related]
45. The renin-angiotensin-aldosterone system in human hepatic cirrhosis.
Bernardi M; Gasbarrini G
Isr J Med Sci; 1986 Feb; 22(2):70-7. PubMed ID: 3512474
[TBL] [Abstract][Full Text] [Related]
46. The effects of chronic treatment with octreotide versus octreotide plus midodrine on systemic hemodynamics and renal hemodynamics and function in nonazotemic cirrhotic patients with ascites.
Kalambokis G; Economou M; Fotopoulos A; Al Bokharhii J; Pappas C; Katsaraki A; Tsianos EV
Am J Gastroenterol; 2005 Apr; 100(4):879-85. PubMed ID: 15784036
[TBL] [Abstract][Full Text] [Related]
47. Effect of indomethacin and prostaglandin A1 on renal function and plasma renin activity in alcoholic liver disease.
Boyer TD; Zia P; Reynolds TB
Gastroenterology; 1979 Aug; 77(2):215-22. PubMed ID: 447034
[TBL] [Abstract][Full Text] [Related]
48. Ascites in liver diseases.
Gentilini P; Laffi G
Ann Ital Med Int; 1991; 6(1 Pt 2):148-55. PubMed ID: 1742150
[TBL] [Abstract][Full Text] [Related]
49. Cardio-renal effects of the A1 adenosine receptor antagonist SLV320 in patients with heart failure.
Mitrovic V; Seferovic P; Dodic S; Krotin M; Neskovic A; Dickstein K; de Voogd H; Böcker C; Ziegler D; Godes M; Nakov R; Essers H; Verboom C; Hocher B
Circ Heart Fail; 2009 Nov; 2(6):523-31. PubMed ID: 19919976
[TBL] [Abstract][Full Text] [Related]
50. Hepatorenal syndrome.
Gattoni A; Marotta F; Vangieri B; Pisani G; Cristiano F
Clin Ter; 2004 Sep; 155(9):375-89. PubMed ID: 15700631
[TBL] [Abstract][Full Text] [Related]
51. Midodrine in patients with cirrhosis and refractory or recurrent ascites: a randomized pilot study.
Singh V; Dhungana SP; Singh B; Vijayverghia R; Nain CK; Sharma N; Bhalla A; Gupta PK
J Hepatol; 2012 Feb; 56(2):348-54. PubMed ID: 21749847
[TBL] [Abstract][Full Text] [Related]
52. Effects of nitric oxide inhibition by methylene blue in cirrhotic patients with ascites.
Kalambokis G; Economou M; Fotopoulos A; Bokharhii JA; Christos P; Paraskevi K; Konstantinos P; Katsaraki A; Tsianos EV
Dig Dis Sci; 2005 Oct; 50(10):1771-7. PubMed ID: 16187171
[TBL] [Abstract][Full Text] [Related]
53. Vasoactive factors in decompensated cirrhosis. Effect of acute plasma expansion.
La Villa G; Laffi G; Pinzani M; Pampana A; Mannelli M; Smorlesi C; Gentilini P
Boll Soc Ital Biol Sper; 1984 Mar; 60(3):535-41. PubMed ID: 6561965
[TBL] [Abstract][Full Text] [Related]
54. The effect of propranolol on renal sodium handling in patients with cirrhosis.
Shohat J; Iaina A; Serban I; Theodor E; Eliahou HE
Biomedicine; 1979 Sep; 31(5):128-31. PubMed ID: 508894
[TBL] [Abstract][Full Text] [Related]
55. Effects of contrast media on renal function in patients with cirrhosis: a prospective study.
Guevara M; Fernández-Esparrach G; Alessandria C; Torre A; Terra C; Montañà X; Piera C; Alvarez ML; Jiménez W; Ginès P; Arroyo V
Hepatology; 2004 Sep; 40(3):646-51. PubMed ID: 15349903
[TBL] [Abstract][Full Text] [Related]
56. Interleukin-6, nitric oxide, and the clinical and hemodynamic alterations of patients with liver cirrhosis.
Genesca J; Gonzalez A; Segura R; Catalan R; Marti R; Varela E; Cadelina G; Martinez M; Lopez-Talavera JC; Esteban R; Groszmann RJ; Guardia J
Am J Gastroenterol; 1999 Jan; 94(1):169-77. PubMed ID: 9934750
[TBL] [Abstract][Full Text] [Related]
57. Taurine-induced diuresis and natriuresis in cirrhotic patients with ascites.
Gentile S; Bologna E; Terracina D; Angelico M
Life Sci; 1994; 54(21):1585-93. PubMed ID: 8196477
[TBL] [Abstract][Full Text] [Related]
58. Systemic hemodynamic, forearm vascular, renal, and humoral responses to sustained cardiopulmonary baroreceptor deactivation in well-compensated cirrhosis.
Wong F; Logan A; Blendis L
Hepatology; 1995 Mar; 21(3):717-24. PubMed ID: 7875669
[TBL] [Abstract][Full Text] [Related]
59. [The effect of dopamine on hemodynamic and hormonal parameters in liver cirrhosis].
Tesar V; Petrtýl J; Jedlicka J; Horký K; Gregorová I; Kopecká J; Marek J; Marecek Z; Kordac V
Cas Lek Cesk; 1990 Apr; 129(17):520-5. PubMed ID: 2140956
[TBL] [Abstract][Full Text] [Related]
60. [Renal and extra-renal mechanisms of sodium and water retention in cirrhosis with ascites].
Peña JC
Rev Invest Clin; 1995; 47(1):63-79. PubMed ID: 7777718
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
